Allmed Medical Products Co.,Ltd

Allmed Medical Products Co.,Ltd

002950.SZ
Allmed Medical Products Co.,LtdCN flagShenzhen Stock Exchange
8.93
CNY
-0.48
- -
5.66BMarket Cap
Allmed Medical Products Co.,Ltd
002950.SZ
(Shenzhen Stock Exchange)

Recent

price

8.93

P/E

ratio

- -

div

yld

- -

ROIC.AI

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
- -
- -
2.68
3.05
3.61
3.83
6.06
4.63
6.65
4.24
5.32
5.93
5.4
Revenue per Share
- -
- -
0.43
0.42
0.41
0.53
1.83
0.68
0.64
0.17
0.59
0.4
0.6
Basic EPS, GAAP
- -
- -
0.54
-0.37
-0.51
0.07
1.89
0.13
1.19
0.21
0.89
0.74
-0.22
Free Cash Flow per Basic Share
- -
- -
0.51
0.33
0.06
0.17
0.42
0.91
0.26
0.1
0.07
0.08
0.09
Dividend per Share
- -
- -
1.04
1.24
1.59
1.93
3.53
3.3
3.66
3.63
4.29
4.65
4.49
Book Value per Share
- -
- -
1.56
1.62
2.03
3.09
4.27
3.94
4.45
4.48
5.07
5.32
5.25
Tangible Book Value per Share
- -
- -
582
561
561
615
633
632
633
649
625
619
633
Basic Weighted Avg Shares
1,509
1,585
1,558
1,711
2,028
2,352
3,834
2,926
4,211
2,757
3,326
3,672
3,421
Sales/Revenue/Turnover
16.95
17.22
19.07
16.37
15.57
17.66
32.49
15.66
20.84
11.8
14.77
16.2
14.73
Operating Margin (%)
66
74
77
84
111
121
142
147
193
227
229
243
- -
Depreciation Expense
198
157
248
234
228
326
1,158
431
407
110
369
249
382
Net Income, GAAP
16.97
18.89
15.49
17.35
18.12
17.75
13.31
14.55
16.55
38.35
18.84
16.79
18.15
Effective Tax Rate (%)
13.15
9.9
15.93
13.66
11.23
13.85
30.19
14.74
9.66
4
11.08
6.78
11.15
Profit Margin (%)
-39
277
216
194
336
1,043
1,370
605
332
454
820
1,076
1,028
Working Capital
- -
- -
- -
154
228
187
101
128
111
151
90
173
43
LT Debt
742
994
1,018
1,099
1,322
2,059
2,923
2,752
3,131
3,211
3,448
3,615
3,597
Total Equity
- -
14.87
16.74
14.04
12.29
13.42
31.44
9.45
17.97
4.87
9.6
11.52
9.9
Return on Invested Capital (%)
- -
13.67
23.33
21.23
15.61
19.12
44.94
13.07
13.17
4.11
11.63
7.23
11.52
Return on Capital (%)
- -
23.25
37.9
35.99
28.77
31.43
67.76
19.96
18.46
4.72
14.63
8.95
14.21
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
571
630
481
LT Borrowings
89
109
42
LT Finance Leases
- -
- -
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
633
633
633
Market Capitalization
5,530
5,630
5,446

Working Capital

FRC

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
1,928
2,128
1,983
Cash, Cash Equivalents & STI
668
892
754
Accounts Receivable, Net
478
435
461
Inventories
615
599
534
Total Current Liabilities
1,108
1,168
955
Payables & Accruals
- -
- -
- -
ST Debt
571
630
481
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
15.11%
4.54%
4.84%
Free Cash Flow
366.71%
181.12%
-17.64%
Net Income, GAAP
40.82%
12.04%
-32.49%
Sales/Revenue/Turnover
12.24%
3.35%
10.38%
Total Cash Common Dividend
40.63%
-5.79%
18.68%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
746
835
868
876
3,326
2025
759
918
1,075
- -
3,672
2026
896
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.15
- -
- -
- -
0.59
2025
0.14
- -
- -
- -
0.4
2026
0.18
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
- -
- -
- -
0.07
2025
0.01
- -
- -
- -
0.08
2026
0.01
- -
- -
- -
- -
Business
Allmed Medical Products Co., Ltd. specializes in the comprehensive development, production, and distribution of an extensive range of medical dressings and healthcare materials. The company’s offerings are categorized into several key areas, including a wide array of wound care and nursing products. These encompass general wound management items such as elastic and adhesive bandages, specialized oil emulsion and xeroform gauze dressings, various woven and non-woven gauze swabs, absorbent fluffy bandages and sponges, abdominal pads, non-stick pads, and petrolatum gauze. Allmed also provides advanced wound care solutions. Beyond wound care, the company delivers essential operating room and surgical products, which feature X-ray non-woven and gauze swabs, OR towels, laparotomy and neuro sponges, X-ray detectable gauze and non-woven balls, as well as a variety of surgical gowns and drapes. Additionally, Allmed is a significant provider of infection control materials and customized procedure kits. For patient care, its product portfolio includes disposable nursing pads and medical drapes. Allmed Medical Products Co., Ltd. operates both domestically and internationally, exporting its comprehensive product line to over 70 countries and regions across six continents, establishing a notable global presence, with key markets including the United States, Canada, Germany, and Japan. The company was originally established in Hong Kong in 1997 and subsequently listed on the Shenzhen Stock Exchange in March 2019 under the ticker 002950.SZ. Headquartered in Shenzhen, People's Republic of China, Allmed is recognized for its integrated, large-scale, and intelligent manufacturing capabilities across medical dressings, infection control products, and medical non-woven items. Recent activities include participation in global medical conferences, as well as share repurchase programs and a strategic acquisition in the Chinese medical products sector.